bit.ly/4AerF4Z
bit.ly/4AerF4Z
Mortality and prognostic factors in invasive aspergillosis: a systematic review and individual patient data meta-analysis
www.thelancet.com/journals/lan...
Mortality and prognostic factors in invasive aspergillosis: a systematic review and individual patient data meta-analysis
www.thelancet.com/journals/lan...
Abouda et al. — ASIDE Internal Medicine
https://asidejournals.com/index.php/internal-medicine/article/view/376
#InternalMedicine #OpenAccess
Abouda et al. — ASIDE Internal Medicine
https://asidejournals.com/index.php/internal-medicine/article/view/376
#InternalMedicine #OpenAccess
These capabilities substantially improve disease management and prognostic outcomes. Which part of this surprised you most?
aethertek.org
#consciousness #quantum #light #cellbiology #aethertek
These capabilities substantially improve disease management and prognostic outcomes. Which part of this surprised you most?
aethertek.org
#consciousness #quantum #light #cellbiology #aethertek
A new 12-gene immune-related gene signature (IRGS) developed via machine learning predicts overall survival across cohorts, independently of clinical covariates: https://doi.org/10.1111/cas.70523
A new 12-gene immune-related gene signature (IRGS) developed via machine learning predicts overall survival across cohorts, independently of clinical covariates: https://doi.org/10.1111/cas.70523
academic.oup.com/ajh/article/... #WeekendReads
academic.oup.com/ajh/article/... #WeekendReads
#QualityofLife
@neuroonc.bsky.social
#QualityofLife
@neuroonc.bsky.social
JTWC Warning #07
Issued: 18/0900Z
Official product from the Joint Typhoon Warning Center. Screenshots attached.
#TropicalCyclone #TCXavier #JTWC
JTWC Warning #07
Issued: 18/0900Z
Official product from the Joint Typhoon Warning Center. Screenshots attached.
#TropicalCyclone #TCXavier #JTWC
doi.org/10.1007/s436...
#CancerGenomics
doi.org/10.1007/s436...
#CancerGenomics
meta-analysis360.com/tools/prospe... #AcademicSky
meta-analysis360.com/tools/prospe... #AcademicSky
https://www.researchsquare.com/article/rs-11731164/latest
https://www.researchsquare.com/article/rs-11731164/latest
J2 - KEYNOTE-564 Criteria Provide Less Prognostic Discrimination Than Multilevel Risk Models After Nephrectomy for Renal Cell Carcinoma
Dr. Michael D. Staehler Presents: KEYNOTE-564 criteria pick who gets adjuvant therapy, not who recurs:
J2 - KEYNOTE-564 Criteria Provide Less Prognostic Discrimination Than Multilevel Risk Models After Nephrectomy for Renal Cell Carcinoma
Dr. Michael D. Staehler Presents: KEYNOTE-564 criteria pick who gets adjuvant therapy, not who recurs:
www.tandfonline.com/doi/full/10....
www.tandfonline.com/doi/full/10....